共 37 条
[1]
Chi Z(2011)Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases BMC Cancer 11 85-1463
[2]
Li S(2015)Chinese guidelines on the diagnosis and treatment of melanoma (2015 edition) Ann Transl Med 3 322-1246
[3]
Sheng X(2013)A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma Mol Ther 21 1456-954
[4]
Guo J(2011)Prognostic and clinicopathologic associations of oncogenic J Clin Oncol 29 1239-2147
[5]
Qin S(2002) in metastatic melanoma Nature 417 949-100
[6]
Liang J(2005)Mutations of the N Engl J Med 353 2135-2516
[7]
Cui C(2012) gene in human cancer Eur J Cancer 48 94-332
[8]
Mao L(2011)Distinct sets of genetic alterations in melanoma N Engl J Med 364 2507-111
[9]
Chi Z(2014)Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort Lancet Oncol 15 323-714
[10]
Long GV(2014)For the BRIM-3 study group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation Cancer Chemother Pharmacol 73 103-666